Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
KB-128 is creating great excitement among experts seeking to develop novel therapeutics for treating disorders that can be modulated though 5-HT2C receptors, including schizophrenia, Alzheimer's psychosis, depression, obesity, and addiction.
Lead Product(s): KB-128
Therapeutic Area: Psychiatry/Psychology Product Name: KB-128
Highest Development Status: Phase IProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable October 05, 2023